ASXC News and Press, Asensus Surgical Inc Com From 05/26/21

Agilent price target raised by analysts after better than expected Q2 resultsSeveral firms have lifted the price target for Agilent Technologies (A) after the company raised the fiscal 2021 guidance and reported better-than-expected Q2 FY21 earnings. Agilent has added ~5.1% in ...

Nabriva Therapeutics (NBRV) +51% as its Nabriva antibiotic meets primary endpoint.Pieris Pharmaceuticals (PIRS) +20%.Protagenic Therapeutics (PTIX) +11%.Zscaler (ZS) +11% on Q3 results.Urban Outfitters (URBN) +11% on Q1 results.Selecta Biosciences (SELB) +10% as board dire...

Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that Anthony Fernando, President and Chief Executive Officer, and Sham...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Durham, North Carolina-based medical device business Asensus Surgical (NYSEAMERICAN: ASXC ) had an eventful first quarter of 2021. So did the folks who held ASXC stock, as it was a wild three months. Source: Dmytr...

Palm Beach, FL – May 12, 2021 – Autism spectrum disorder (ASD) represents a group of neurodevelopmental disorders or disabilities; it is a heritable and a polygenic disorder. Autism spectrum disorder is lifelong and typically emerges during early childhood. Children show ASD-r...

Asensus Surgical, Inc. (ASXC) Q1 2021 Earnings Conference Call May 11, 2021, 4:30 PM ET Company Participants Mark Klausner - Westwicke, IR Anthony Fernando - President and CEO Shameze Rampertab - Chief Financial Officer Conference Call Participants RK - H. C. Wainwright Presentation Operator ...

Shares of Asensius Surgical (ASXC) have fallen slightly in after-hours trading despite a Q1 beat in EPS and revenue.Net loss narrowed year-over-year from 59 cents per share to 6 cents per share.Q1 revenue was $2.1M compared to $0.6M in the year-ago period.$1.3M of that revenue was from the Se...

Asensus Surgical (ASXC): Q1 Non-GAAP EPS of -$0.06 beats by $0.01; GAAP EPS of -$0.08 misses by $0.01.Revenue of $2.08M (+246.7% Y/Y) beats by $0.71M.For the full year 2021, the Company continues to expect to install 10 - 12 new Senhance Surgical Systems.The Company had cash and cash equivale...

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the first quarter 2021. R...

LAKUMED hospital in Landshut-Achdorf to become fifth Senhance hospital in Germany Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery&#...